Neoadjuvant Hyperthermia and Chemoradiotherapy for Borderline Resectable Pancreatic Cancer
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2021-03-01 / Gan To Kagaku Ryoho 2021 Mar;48(3):388-390Dendritic Cell-based Immunotherapy Pulsed With Wilms Tumor 1 Peptide and Mucin 1 as an Adjuvant Therapy for Pancreatic Ductal Adenocarcinoma After Curative Resection: A Phase I/IIa Clinical Trial
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2020-10-01 / Anticancer Res 2020 Oct;40(10):5765-5776Modulated Electro-Hyperthermia Resolves Radioresistance of Panc1 Pancreas Adenocarcinoma and Promotes DNA Damage and Apoptosis In Vitro
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2020-07-19 / Int J Mol Sci 2020 Jul;21(14)Rewiring local immune milieu by boosting dendritic cell for pancreatic cancer treatment
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2020-07-02 / Signal Transduct Target Ther 2020 Jul;5(1):114Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2020-07-01 / J Immunother Cancer 2020 07;8(2)Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2020-03-16 / Cancer Cell 2020 03;37(3):289-307.e9Prophylactic dendritic cell vaccination controls pancreatic cancer growth in a mouse model
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2020-01-01 / Cytotherapy 2020 01;22(1):6-15Dendritic cell immunotherapy induces anti-tumor effect in a transgenic mouse model of pancreatic ductal adenocarcinoma
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2019-11-01 / Am J Cancer Res 2019;9(11):2456-2468Dendritic cells in pancreatic cancer immunotherapy: Vaccines and combination immunotherapies
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2019-10-17 / Pathol. Res. Pract. 2019 Dec;215(12):152691
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de